Boehringer Ingelheim and Eli Lilly and Company have announced the availability of My Well Planner, a new online progra…
Health
Have Type 2 Diabetes? Take This Survey
Amy Tenderich of Diabetes Mine is compiling data for an article in the ADA journal Diabetes Spectrum. The article will …
Lilly Diabetes Launches Glucagon Mobile App
Lilly Diabetes today announced the release of a new mobile application designed for caregivers and healthcare providers …
FDA Approves Janssen’s NUCYNTA ER for Diabetic Peripheral Neuropathy Pain
The U.S. FDA has approved the supplemental New Drug Application (sNDA), submitted by Janssen Pharmaceuticals, for NUCYNT…
Omnipod Put to the Test
I have been extremely happy with the Omnipod and require less insulin than I used to because I never detach. I feel th…
Pumping Insulin, The Fifth Edition
We recently received a copy of Pumping Insulin, the 5th Edition, which provides up-to-date information on how to use an…
Diabetes and Cancer: Can Metformin Treat Both?
The association between diabetes and cancer was first noted over 100 years ago, but physicians have become increasingly …
A Second Chance at Diabetes Management
After months of chemotherapy and surgery, the cancer was in remission. I had survived. What was diabetes compared to tha…
Pfizer Drug Lyrica Fails in Phase 3 Study In Patients With Diabetic Peripheral Neuropathy
Pfizer Inc. has announced that a Phase 3 randomized withdrawal design study for Lyrica (pregabalin) in patients with ina…
Proving the Hygiene Hypothesis?
The hygiene hypothesis sounds plausible, especially in light of studies that have found increasing rates of diseases lik…
